Kevin Nolan, a MSD manager, saves his time off for December when he works a side job as "Cocoa Santa" during the Christmas ...

MSD declines to exercise option for EVX-B2 developmentEvaxion is now able to out-license EVX-B2 to another partnerEvaxion maintains its strong ...

After years of complaints, MSD is taking steps to mitigate odors emitted from the combined sewer system running beneath much of Louisville.

Evaxion Biotech ( ($EVAX) ) has provided an announcement. On December 19, 2025, Evaxion A/S reported that its collaboration partner MSD chose not ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump administration to ensure its prescription medicines are both accessible and ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

Sexual abuse support services facing cuts in the new year have been given an extra six months, but are being told not to expect any more than that. The government planned to redirect $1.7 million from ...

Today, new-generation cancer drugs have significantly improved both effectiveness and safety, especially targeted therapies.

COLUMBUS – Heritage Ohio and the Ohio Main Street Program are proud to announce the National Accreditation of Main Street ...

Hansa Biopharma AB, ("Hansa" or "the Company"), , today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imlifidase. The Company is ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...